Bobby Kuruvilla, DPM
Foot & Ankle Surgery · North Andover, MANPI 1801800701
Payments from drug & device makers
What this record shows
This record is dominated by education: $1,685 of the $2,048 with a category attached, or 82.3%. Kairos Surgical Inc accounts for 83.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2021 at $1,253 and has fallen 95.4% since, to $58 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in MA, where the typical reported total is $1,627.
Across 14 payments — averaging $146.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kairos Surgical Inc$2K
- Treace Medical Concepts, Inc.$123
- Integra Lifesciences Corporation$70
- ANI Pharmaceuticals, Inc.$43
- Bioventus LLC$41
- Smith+Nephew$37
- plus $19 from 1 others
What the payments were for
- Food & beverage$36318%
- Education$1,68582%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kairos Surgical Inc | 4 | $1,716 |
| Treace Medical Concepts, Inc. | 1 | $123 |
| Integra Lifesciences Corporation | 2 | $70 |
| ANI Pharmaceuticals, Inc. | 2 | $43 |
| Bioventus LLC | 2 | $41 |
| Smith+Nephew | 2 | $37 |
| Kerecis Limited | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,048 in reported general payments places this provider in the 50th percentile of 122 foot & ankle surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 271 | $2,094 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 55 | $657 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 59 | $575 |
| Ibuprofen | 59 | $359 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 53 | $279 |
| Diclofenac Sodium | 11 | $253 |
| Meloxicam | 40 | $167 |
| Oxycodone Hcl | 21 | $155 |
| Tramadol Hcl | 14 | $110 |
| Doxycycline Hyclate | 11 | $96 |
| Ondansetron OdtOndansetron | 24 | $86 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 11 | $84 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 14 | $81 |
| Levofloxacin | 25 | $76 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in North Andover
- Harry SchneiderCambridge$174K
- Craig LareauSpringfield$115K
- David SipalaBrighton$94K
- Philip BasileCambridge$90K
- Michael SgangaNatick$90K
- Joseph FleckNorth Chelmsford$35K
- Michael SkoniecznyPlymouth$33K
- Richard BakerHyannis$16K
- Mark SlovenkaiWaltham$14K
- Jaeyoung KimBoston$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.